GENEVA, June 22 -- GUANGDONG RAYNOVENT BIOTECH CO., LTD. (Room 501, Building D, No. 288, Shenzhou Road, Huangpu DistrictGuangzhou, Guangdong 510700), 广东众生睿创生物科技有限公司 (中国广东省广州市黄埔区神舟路288号D栋501房) filed a patent application (PCT/CN2024/137939) for "HETEROCYCLIC GLP-1 RECEPTOR AGONIST AND USE THEREOF" on Dec 09, 2024. With publication no. WO/2025/124357, the details related to the patent application was published on Jun 19, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system...